ImmunoCellular Therapeutics To Report Fourth Quarter And Full Year 2016 Financial Results On March 9, 2017 Post author:Sam Post published:March 6, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like <b>Congress</b> Ignores <b>Trump</b>: the NIH Will Get $2 Billion Boost Despite Proposed Cuts May 1, 2017 IntelliPharmaCeutics Announces FDA Acceptance For Filing Of NDA For Rexista (Oxycodone Hydrochloride Extended Release), An Abuse Deterrent Opioid Analgesic For The Treatment Of Moderate To Severe Pain February 2, 2017 Aclaris Scoops Up St. Louis Startup in Deal Worth Up to $100M August 7, 2017
<b>Congress</b> Ignores <b>Trump</b>: the NIH Will Get $2 Billion Boost Despite Proposed Cuts May 1, 2017
IntelliPharmaCeutics Announces FDA Acceptance For Filing Of NDA For Rexista (Oxycodone Hydrochloride Extended Release), An Abuse Deterrent Opioid Analgesic For The Treatment Of Moderate To Severe Pain February 2, 2017